HHS / ARPA-H
Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease
Rapid Comprehensive Diagnostic Test for Multi-System Autoimmune Disease is a funding opportunity from HHS / ARPA-H, closing September 30, 2027.
Overview
The purpose of this topic is to spur the development of novel, rapid diagnostic assays for multi-system autoimmune disease, which represents an unmet healthcare need. Moreover, in its ideal embodiment this diagnostic test might allow typical primary care physicians to diagnose and predict tissue-specific autoimmune…